Recruiting

MedlyPeds Feasibility Study

SickKids and UHN have developed MedlyPeds which is a smart phone application designed to remotely monitor patients with heart disease. This is a feasibility study which will enroll up to 30 patients with different types of heart disease to see which patient types may benefit the most from MedlyPeds if it were to be used for clinical monitoring. The study is gathering feedback about the app from patients, parents and clinicians to confirm how it needs to be modified to better serve the purpose in a future trial.

ClinicalTrials.gov IDNCT07556185

PhaseNA

Enrollment30

SponsorThe Hospital for Sick Children

Age8 Years

SexALL

I'm interested View official listing

Conditions studied

Pediatric Heart Failure, Congenital Heart Disease (CHD), Acquired Heart Disease, Pulmonary Hypertension, Post Cardiac Surgery

About this study

Interventions

Device: MedlyPeds App — The mobile phone-based telemonitoring system (MedlyPeds) will enable cardiac patients to monitor their weight, blood pressure, and heart rate, using wireless home medical devices. In addition, they will answer questions about their symptoms and wellness using their mobile phone. The device measurements will be automatically and wirelessly transmitted to the mobile phone and then to a data server. Automated and individualized self-care messages, developed with the assistance of healthcare providers, will subsequently be sent to the patient based on the readings and reported symptoms.

Primary outcomes

Percentage of MedlyPeds App Daily Check-In Completion (3 months)
Feasibility and acceptability of Medly Peds (3 months)

Eligibility information

Inclusion Criteria: 1. Consent provided. 2. Aged 8-18 years of age. 3. Ability to comply with using Medly (ex. able to stand on the weight scale, able to answer symptom questions, etc.) 4. Followed at the Hospital for Sick Children Cardiology Clinic for any of the following reasons: 1. Heart failure of any etiology 2. Congenital heart disease 3. Acquired heart disease (eg. Kawasaki disease, rheumatic heart disease, connective tissue disorders etc) 4. Pulmonary hypertension 5. Post-cardiac surgery including heart transplant and ventricular assist devices Exclusion Criteria: 1. Unable to read or write in English. 2. Participating in another clinical trial that may confound the results.\* \*Participant may be re-screened for eligibility at a later date.

Study locations

The Hospital for Sick Children, Toronto, Ontario M5G1X8 Canada

Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.

Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.